These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 9759879

  • 1. In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6.
    Peters M, Blinn G, Solem F, Fischer M, Meyer zum Büschenfelde KH, Rose-John S.
    J Immunol; 1998 Oct 01; 161(7):3575-81. PubMed ID: 9759879
    [Abstract] [Full Text] [Related]

  • 2. Soluble IL-6 receptor leads to a paracrine modulation of the IL-6-induced hepatic acute phase response in double transgenic mice.
    Peters M, Odenthal M, Schirmacher P, Blessing M, Fattori E, Ciliberto G, Meyer zum Buschenfelde KH, Rose-John S.
    J Immunol; 1997 Aug 01; 159(3):1474-81. PubMed ID: 9233646
    [Abstract] [Full Text] [Related]

  • 3. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
    Kimura T, Wang J, Minamiguchi H, Fujiki H, Harada S, Okuda K, Kaneko H, Yokota S, Yasukawa K, Abe T, Sonoda Y.
    Stem Cells; 2000 Aug 01; 18(6):444-52. PubMed ID: 11072033
    [Abstract] [Full Text] [Related]

  • 4. Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes.
    Gabay C, Silacci P, Genin B, Mentha G, Le Coultre C, Guerne PA.
    Eur J Immunol; 1995 Aug 01; 25(8):2378-83. PubMed ID: 7545121
    [Abstract] [Full Text] [Related]

  • 5. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G, Küster A, Hemmann U, Keul R, Horsten U, Martens A, Graeve L, Wijdenes J, Heinrich PC.
    J Immunol; 1998 Dec 01; 161(11):6347-55. PubMed ID: 9834125
    [Abstract] [Full Text] [Related]

  • 6. I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion.
    Fischer M, Goldschmitt J, Peschel C, Brakenhoff JP, Kallen KJ, Wollmer A, Grötzinger J, Rose-John S.
    Nat Biotechnol; 1997 Feb 01; 15(2):142-5. PubMed ID: 9035138
    [Abstract] [Full Text] [Related]

  • 7. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.
    Ganapathi MK, Weizer AK, Borsellino S, Bukowski RM, Ganapathi R, Rice T, Casey G, Kawamura K.
    Cell Growth Differ; 1996 Jul 01; 7(7):923-9. PubMed ID: 8809410
    [Abstract] [Full Text] [Related]

  • 8. The designer cytokine hyper-IL-6 mediates growth inhibition and GM-CSF-dependent rejection of B16 melanoma cells.
    Ozbek S, Peters M, Breuhahn K, Mann A, Blessing M, Fischer M, Schirmacher P, Mackiewicz A, Rose-John S.
    Oncogene; 2001 Feb 22; 20(8):972-9. PubMed ID: 11314032
    [Abstract] [Full Text] [Related]

  • 9. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression.
    Oh JW, Van Wagoner NJ, Rose-John S, Benveniste EN.
    J Immunol; 1998 Nov 01; 161(9):4992-9. PubMed ID: 9794436
    [Abstract] [Full Text] [Related]

  • 10. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.
    Atreya R, Mudter J, Finotto S, Müllberg J, Jostock T, Wirtz S, Schütz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schürmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, Neurath MF.
    Nat Med; 2000 May 01; 6(5):583-8. PubMed ID: 10802717
    [Abstract] [Full Text] [Related]

  • 11. IL-6 transsignaling: the in vivo consequences.
    Jones SA, Richards PJ, Scheller J, Rose-John S.
    J Interferon Cytokine Res; 2005 May 01; 25(5):241-53. PubMed ID: 15871661
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity.
    Sun RX, Gennaro C, Rocco S, Gu ZJ, Klein B.
    Eur Cytokine Netw; 1997 Mar 01; 8(1):51-6. PubMed ID: 9110148
    [Abstract] [Full Text] [Related]

  • 13. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
    Moritz RL, Ward LD, Tu GF, Fabri LJ, Ji H, Yasukawa K, Simpson RJ.
    Growth Factors; 1999 Mar 01; 16(4):265-78. PubMed ID: 10427501
    [Abstract] [Full Text] [Related]

  • 14. Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130).
    Geisterfer M, Richards CD, Gauldie J.
    Cytokine; 1995 Aug 01; 7(6):503-9. PubMed ID: 8580365
    [Abstract] [Full Text] [Related]

  • 15. Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells.
    Finotto S, Eigenbrod T, Karwot R, Boross I, Doganci A, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Rose-John S, Galle PR, Neurath MF.
    Int Immunol; 2007 Jun 01; 19(6):685-93. PubMed ID: 17496315
    [Abstract] [Full Text] [Related]

  • 16. The regenerative activity of interleukin-6.
    Galun E, Rose-John S.
    Methods Mol Biol; 2013 Jun 01; 982():59-77. PubMed ID: 23456862
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6.
    Gaillard JP, Mani JC, Liautard J, Klein B, Brochier J.
    Eur Cytokine Netw; 1999 Mar 01; 10(1):43-8. PubMed ID: 10210772
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of interleukin-6-transsignaling via gp130-Fc in hemorrhagic shock and sepsis.
    Mees ST, Toellner S, Marx K, Faendrich F, Kallen KJ, Schroeder J, Haier J, Kahlke V.
    J Surg Res; 2009 Dec 01; 157(2):235-42. PubMed ID: 19589542
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-6 receptor-interleukin-6 fusion proteins with enhanced interleukin-6 type pleiotropic activities.
    Chebath J, Fischer D, Kumar A, Oh JW, Kolett O, Lapidot T, Fischer M, Rose-John S, Nagler A, Slavin S, Revel M.
    Eur Cytokine Netw; 1997 Dec 01; 8(4):359-65. PubMed ID: 9459615
    [Abstract] [Full Text] [Related]

  • 20. Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes.
    Igaz P, Tóth S, Rose-John S, Madurka I, Fejér G, Szalai C, Falus A.
    Cytokine; 1998 Aug 01; 10(8):620-6. PubMed ID: 9722935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.